What the Research Shows
Dental applications rarely make regenerative medicine headlines, which is a shame, because the periodontal research is among the cleanest in the field: randomized, saline-controlled, with millimeters of measured tissue as the endpoint.
A multicenter randomized clinical trial in Signal Transduction and Targeted Therapy, a Nature Portfolio journal (2025), studied injections of allogeneic dental pulp stem cells in 132 patients with chronic periodontitis across two centers, against saline control. The full open-access results: the injection was safe, produced greater improvement in bone defect depth than saline, and in more severe stage III periodontitis delivered significantly better attachment outcomes, a 1.67 millimeter improvement versus 1.03 with saline, through a non-invasive injection where current regenerative dentistry is typically surgical.
The pooled literature agrees on direction: a 2023 meta-analysis in BMC Oral Health of five randomized trials covering 118 patients found significantly better clinical attachment level with cell-based therapy, a 2025 GRADE-rated meta-analysis of ten clinical trials found significant improvements in probing depth, attachment level, and intrabony defect measures, and earlier pooled analyses in the Journal of Periodontal Research and of periodontal cell therapy broadly reached consistent conclusions.





